| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.4683 | 34 |
| GSM780708 | Untreated after 4 days (C2_1) | 37.2975 | 2 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.1705 | 18 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.3558 | 29 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.3764 | 34 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.4973 | 20 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 41.6821 | 12 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.606 | 16 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.1883 | 33 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 43.5479 | 20 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.9129 | 36 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.1594 | 18 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 41.8373 | 12 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.9212 | 27 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 40.9571 | 9 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.6848 | 26 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.754 | 21 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 39.4897 | 5 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.076 | 18 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.8737 | 36 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 41.6006 | 12 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.0113 | 22 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.8823 | 27 |